Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: KKR Genetic Disorder LP, owns ten percent - or more - of the company

Transaction date: May 12, 2025

Reporting date: May 14, 2025

Average share price: 34.2

Sold 6000000.0 shares for 205200000.0